These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 26611599)

  • 1. Gene Therapy Models of Alzheimer's Disease and Other Dementias.
    Combs B; Kneynsberg A; Kanaan NM
    Methods Mol Biol; 2016; 1382():339-66. PubMed ID: 26611599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus.
    Rodriguez GA; Barrett GM; Duff KE; Hussaini SA
    PLoS Biol; 2020 Aug; 18(8):e3000851. PubMed ID: 32822389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies.
    Pires G; McElligott S; Drusinsky S; Halliday G; Potier MC; Wisniewski T; Drummond E
    Acta Neuropathol Commun; 2019 Dec; 7(1):195. PubMed ID: 31796108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Pathogenesis of the Tauopathies.
    Götz J; Halliday G; Nisbet RM
    Annu Rev Pathol; 2019 Jan; 14():239-261. PubMed ID: 30355155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in tau-based therapeutics for neurodegenerative diseases.
    Medina M
    Recent Pat CNS Drug Discov; 2011 Jan; 6(1):20-30. PubMed ID: 21118095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic Drosophila models of Alzheimer's disease and tauopathies.
    Iijima-Ando K; Iijima K
    Brain Struct Funct; 2010 Mar; 214(2-3):245-62. PubMed ID: 19967412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model.
    Emmerson JT; Do Carmo S; Liu Y; Shalhoub A; Liu A; Bonomo Q; Malcolm JC; Breuillaud L; Cuello AC
    Neurobiol Dis; 2023 Aug; 184():106227. PubMed ID: 37454780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studying tau protein propagation and pathology in the mouse brain using adeno-associated viruses.
    Wegmann S; Bennett RE; Amaral AS; Hyman BT
    Methods Cell Biol; 2017; 141():307-322. PubMed ID: 28882310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tau in Alzheimer's disease.
    Trojanowski JQ; Lee VM
    Med Clin North Am; 2002 May; 86(3):615-27. PubMed ID: 12168561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.
    Ballatore C; Lee VM; Trojanowski JQ
    Nat Rev Neurosci; 2007 Sep; 8(9):663-72. PubMed ID: 17684513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic animal models of tauopathies.
    Lee VM; Kenyon TK; Trojanowski JQ
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):251-9. PubMed ID: 15615643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Alzheimer's disease dementias: anatomic, clinical, and molecular correlates.
    Hou CE; Carlin D; Miller BL
    Can J Psychiatry; 2004 Mar; 49(3):164-71. PubMed ID: 15101498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Animal models of tauopathies].
    Higuchi M
    Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential vulnerability of the dentate gyrus to tauopathies in dementias.
    Kawles A; Minogue G; Zouridakis A; Keszycki R; Gill N; Nassif C; Coventry C; Zhang H; Rogalski E; Flanagan ME; Castellani R; Bigio EH; Mesulam MM; Geula C; Gefen T
    Acta Neuropathol Commun; 2023 Jan; 11(1):1. PubMed ID: 36597124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies.
    Silva MC; Haggarty SJ
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.